Advertisement
U.S. markets open in 5 hours 10 minutes

Theriva Biologics, Inc. (TOVX)

NYSE American - Nasdaq Real Time Price. Currency in USD
Visitors trend2W10W9M
1.3000+0.0200 (+1.56%)
At close: 04:00PM EST
1.3000 0.00 (0.00%)
After hours: 07:47PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close1.2800
Open1.2900
Bid1.2500 x 1800
Ask0.0000 x 1100
Day's Range1.2600 - 1.3200
52 Week Range1.2200 - 17.0000
Volume74,574
Avg. Volume3,467,871
Market Cap3.617M
Beta (5Y Monthly)1.34
PE Ratio (TTM)N/A
EPS (TTM)-32.5900
Earnings DateNov 12, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est90.50
  • Associated Press Finance

    Theriva Biologics: Q3 Earnings Snapshot

    ROCKVILLE, Md. AP) — Theriva Biologics, Inc. TOVX) on Tuesday reported a loss of $7.7 million in its third quarter.

  • GlobeNewswire

    Theriva Biologics Selected as Finalist in International Competition for Merck KGaA's EMEA Advance Biotech Grant

    Winner to be Presented at BIO-Europe 2024 in Stockholm, SwedenROCKVILLE, Md., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Theriva™ Biologics (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today announced selection as one of five finalists for Merck KGaA's EMEA Advance Biotech Grant. Finalists for the grant will present to a six-judge panel from Merck’s Emerging Biotech group during BIO Europe 20